default author photo

Shannon Winski

Pfizer Boulder Research & Development

United States

  • Pfizer Boulder Research & Development

SCHOLARLY PAPERS

1

DOWNLOADS

25

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

MEK Inhibition Enhances Presentation of Targetable MHC-I Tumor Antigens in Mutant Melanomas

Number of pages: 65 Posted: 26 Jan 2022
Lauren Stopfer, Nicholas J. Rettko, Owen Leddy, Joshua M. Mesfin, Eric Brown, Shannon Winski, Bryan Bryson, James A. Wells and Forest White
Massachusetts Institute of Technology (MIT) - Department of Biological Engineering, University of California, San Francisco (UCSF), Massachusetts Institute of Technology (MIT), Massachusetts Institute of Technology (MIT), Pfizer Boulder Research & Development, Pfizer Boulder Research & Development, Massachusetts Institute of Technology (MIT), University of California, San Francisco (UCSF) and Massachusetts Institute of Technology (MIT) - Department of Biological Engineering
Downloads 25 (1,385,945)

Abstract:

Loading...

MHC-I, Antigen presentation, immunopeptidomics, Mass Spectrometry, kinase inhibitor, melanoma